利用数据和政策干预措施,加强东地中海地区的烟草控制
Randa K Saad1, Nayera S Mostafa2,3, Mahmoud Nabulsi4
1Global Health Development| Eastern Mediterranean Public Health Network, Amman, Jordan.
Frontiers in public health
|October 3, 2025
概括
东地中海地区的国家面临着控制烟草的挑战. 加强执法,提高税收和扩大戒烟服务是有效控制烟草和减少新产品使用的关键.
科学领域:
- 公共卫生 公共卫生
- 卫生政策 卫生政策
- 控制烟草的控制方式
背景情况:
- 东地中海地区 (EMR) 国家面临着重大烟草控制挑战.
- 世界卫生组织 (WHO) 的MPOWER框架提供了基于证据的烟草控制战略.
- 在EMR中的国家需要在实施和执行烟草控制政策方面得到支持.
研究的目的:
- 支持EMR国家利用证据来加强烟草控制政策和计划.
- 确定有效控制烟草的障碍,并提出可行的对策.
- 加强世卫组织MPOWER框架在EMR中的应用.
主要方法:
- 一个研讨会召集了来自埃及,伊拉克,约旦,黎巴嫩和巴勒斯坦的参与者.
- 参与者回顾了现有的烟草控制政策,并确定了实施挑战.
- 讨论的重点是诸如执法不力,数据不足和行业干预等障碍.
主要成果:
- 确定的主要挑战包括无烟法律的执行力低下,处罚低,监测不足.
- 不足够的数据收集阻碍了传统和新型烟草/蒸汽产品的追踪.
- 烟草行业的干涉破坏了政治意愿和政策的执行.
结论:
- 建议包括在伊拉克和埃及提高烟草税,并在约旦和巴勒斯坦扩大戒烟服务.
- 改善烟草监测系统,如全球烟草监测系统,对于数据驱动的政策至关重要.
- 加强执法,增加罚款和加强机构间协调对于无烟合规至关重要.
更多相关视频
相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
491
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
491
Statistical Methods for Analyzing Epidemiological Data
896
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
896
COPD: Management Using Bronchodilators and Corticosteroids
726
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
726
Therapeutic Drug Monitoring: Affecting Factors
200
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
200
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
International Nursing Organizations II
1.3K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.3K


